Funding {4}
Cancer
CANCER
This trial is being funded by the Irish Cancer Society (Grant code: COV21LYN). University College Dublin is the Host Institution and the Mater Misericordiae University Hospital is the clinical site. The grant award is for €73,752.78 and will cover the employment of a full-time research assistant and other non-personnel costs such as training, specialist data analysis and dissemination costs. Whilst the funding body reviewed a study proposal initially put forward by the clinical researchers, it had no role in the design, data collection, analysis and interpretation of data and will not have any input with regard to writing of the study manuscript(s).